Screener
TransMedics Group, Inc. TMDX Net Income
Net Income at other companies
Other financials
Where this comes from
Reported directly by TransMedics Group, Inc. in its filing.
Tagged under the XBRL concept us-gaap:NetIncomeLoss.
The source filing: TransMedics Group, Inc.’s 10-Q, filed May 5, 2026.
- Filed
- May 5, 2026, 4:15 PM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001193125-26-206453
| Line item | Three Months Ended March 31, 2026 | Three Months Ended March 31, 2025 |
|---|---|---|
| Total other expense, net | (4,812) | (767) |
| Income before income taxes | 8,485 | 26,676 |
| Provision for income taxes | (1,170) | (994) |
| Net income | $7,315 | $25,682 |
| Net income per share: | ||
| Basic | $0.21 | $0.76 |
| Diluted | $0.20 | $0.70 |
| Weighted average common shares outstanding: |
Item 1. Financial Statements (Unaudited)
FAQ
- What is TransMedics Group, Inc.'s net income?
- TransMedics Group, Inc. (TMDX) reported net income of $7.32M in Q1 2026.
- How has TransMedics Group, Inc.'s net income changed year-over-year?
- TransMedics Group, Inc.'s net income decreased by 71.5% year-over-year, from $25.68M to $7.32M.
- What is the long-term trend for TransMedics Group, Inc.'s net income?
- Over 3 years (2021 to 2025), TransMedics Group, Inc.'s net income has grown at a 62.7% compound annual growth rate (CAGR), from -$44.22M to $190.29M.
- What does net income mean?
- The bottom line — total revenue minus all expenses, taxes, and costs. Represents the profit attributable to the company's shareholders after all obligations are met.
Ask your AI about TransMedics Group, Inc.'s net income.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude